Dixon Kaufman, MD, PhD, FACS
- Ray D. Owen Professor and Chairman, Division of Transplantation
- Director, Transplant Service Line
- Section of Kidney and Pancreas Surgery
600 Highland Avenue
BX7375 Clinical Science Center
Madison, WI 53792
- MD, University of Minnesota, 1983
- NIH National Research Service Award, 1986 - 1989
- Surgery Internship and Residency, University of Minnesota, 1983 - 1991
- Transplantation Fellowship, University of Minnesota, 1991 - 1992
- PhD, University of Minnesota, 1994
Dr. Kaufman is involved with the following professional societies:
- American Surgical Association
- American Society of Transplant Surgeons
- Association for Academic Surgery
- Fellow, American College of Surgeons
- Cell Transplant Society, Founding Member
- Central Surgical Association
- International Pancreas and Islet Association, Founding Member
- Society of University Surgeons
- The Surgical Biology Club I
- Transplantation Society
Leadership Roles in Transplantation
Dr. Kaufman has held leadership positions in many facets of the transplant field. He has been very active with the American Society of Transplant Surgeons (ASTS) and has served as Chair of the Education Committee, the Executive Program Committee Chair for the American Transplant Congress, and on the Council of the ASTS. Dr. Kaufman is also very active with the United Network for Organ Sharing (UNOS). He was past Chair of the Pancreas/Islet Transplant Committee, served on the MPSC Committee and currently is Councilor of UNOS Region 7 and a member of the Executive Board. Dr. Kaufman is an associate editor for the American Journal of Transplantation, Transplantation Journal, and Clinical Transplantation Journal.
Dr. Kaufman is certified by the American Board of Surgery in General Surgery. Dr Kaufman’s clinical focus has been on kidney, pancreas, and islet transplantation. He was the first pancreas transplant surgeon in North America to conduct and publish studies regarding steroid-free immunosuppression in pancreas transplantation, and the first to describe the use of alemtuzumab in pancreas transplants.
Dr. Kaufman’s experimental clinical research has focused on immunosuppression minimization in kidney transplant recipients, and human clinical trials of islet transplantation. His basic research efforts have focused on development of a tolerance induction protocol in large animals. It is supported by an NIH UO-1 award as part of the Non-human Primate Tolerance Study Group Consortium.
- Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up.
- Elliott MD, Heitner JF, Kim H, Wu E, Parker MA, Lee DC, Kaufman DB, Bonow RO, Judd R, Kim RJ
- Diabetes Care 2019 Apr 22;
- [PubMed ID: 31010876]
- Isolated pancreas transplantation: Is rank list position related to outcomes of imported grafts?
- Adler JT, Redfield RR, Kaufman DB, Odorico JS
- Am. J. Transplant. 2019 Apr 09;
- [PubMed ID: 30963706]
- Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival.
- Adler JT, Zaborek N, Redfield RR, Kaufman DB, Odorico JS, Sollinger HW
- Am. J. Transplant. 2019 Mar 05;
- [PubMed ID: 30838785]
- Ipsilateral versus contralateral placement of the pancreas allograft in pancreas after kidney transplant recipients.
- Yin H, Arpali E, Leverson GE, Sollinger HW, Kaufman DB, Odorico JS
- Clin Transplant 2018 Aug; 32(8): e13337
- [PubMed ID: 29952108]
- Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantation.
- Arpali E, Al-Qaoud T, Martinez E, Redfield RR, Leverson GE, Kaufman DB, Odorico JS, Sollinger HW
- Am. J. Transplant. 2018 Aug; 18(8): 1977-1985
- [PubMed ID: 29446225]